LGALS3BP and neoplasm: It was demonstrated that LGALS3BP destabilizes E-cadherin–p120-catenin complex through ubiquitination proteasomal degradation, promoting the release and motility of cancer cells from tumor tissues through the weakening of cell–cell adherens junctions [17].